Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05472987 · ClinicalTrials.gov registry record · NA

Robotic Versus Open Ventral Hernia Repair

A NA study of Ventral Hernia, sponsored by Lucas Beffa.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
4
Study locations

NCT05472987: Recruiting NA study of Ventral Hernia, sponsored by Lucas Beffa.

NCT05472987 is a NA study of Ventral Hernia that is actively recruiting participants, run by Lucas Beffa. The registered enrollment target is 200 participants, above the 132-participant average among 18 other Ventral Hernia trials with a reported enrollment target (52% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05472987, a NA study of Ventral Hernia, is actively recruiting participants, sponsored by Lucas Beffa.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
4
Study locations

Study Summary

This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.

Primary Outcome

Time in the hospital after the surgery

Conditions Studied

Interventions

  • PROCEDURE Ventral Hernia Repair

Study Locations (4)

Florida

  • University of Florida Health - Gainesville

Ohio

  • Cleveland Clinic - Cleveland

South Carolina

  • Prisma Health Greenville Memorial Hospital - Greenville

Tennessee

  • University of Tennessee Medical Center, Knoxville - Knoxville

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-07-25
Est. Completion 2027-08-01
Phase NA
Lucas Beffa

1 total trials

What NCT05472987 shows while recruiting

NCT05472987 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 18 other Ventral Hernia trials with a reported enrollment target (52% higher).

The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Ventral Hernia Repair is the first listed.

NCT05472987 reports a single indexed study location in Florida, Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT05472987 about?

NCT05472987 is a clinical study titled "Robotic Versus Open Ventral Hernia Repair". This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.

What is the current status of trial NCT05472987?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-07-25. Estimated completion is 2027-08-01.

What conditions does trial NCT05472987 study?

This clinical trial studies the following conditions: Ventral Hernia.

What interventions are being tested in trial NCT05472987?

The interventions under investigation include: Ventral Hernia Repair (PROCEDURE).

Who is sponsoring clinical trial NCT05472987?

This trial is sponsored by Lucas Beffa, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05472987 being conducted?

This trial has 4 study locations across Florida, Ohio, South Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventral Hernia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05472987's enrollment target sits among peer trials

200 3rd of 18 higher than 14 of 18 other Ventral Hernia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05472987, the US trial registry maintained by the National Library of Medicine. NCT05472987 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.